Merrimack Pharmaceuticals Inc (MACK):企業の財務・戦略的SWOT分析

◆英語タイトル:Merrimack Pharmaceuticals Inc (MACK) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH136492FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Merrimack Pharmaceuticals Inc (MACK) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Merrimack Pharmaceuticals Inc (Merrimack) is a clinical stage biopharmaceutical company that develops and commercializes novel targeted solutions for the treatment of various types of cancers through its understanding of biological markers and cancer pathways. The company’s first commercial product was Onivyde (irinotecan liposome injection), a liposomal formulation for treating advanced pancreatic cancer patients. Merrimack is entitled to receive milestone payments related to sale of Onivyde and MM-436 to Ipsen SA. Merrimack is headquartered in Cambridge, Massachusetts, the US.

Merrimack Pharmaceuticals Inc Key Recent Developments

Nov 05,2020: Merrimack reports third quarter 2020 financial results
Aug 07,2020: Merrimack reports second quarter 2020 financial results
May 07,2020: Merrimack reports first quarter 2020 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Merrimack Pharmaceuticals Inc – Key Facts
Merrimack Pharmaceuticals Inc – Key Employees
Merrimack Pharmaceuticals Inc – Key Employee Biographies
Merrimack Pharmaceuticals Inc – Major Products and Services
Merrimack Pharmaceuticals Inc – History
Merrimack Pharmaceuticals Inc – Company Statement
Merrimack Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Merrimack Pharmaceuticals Inc – Business Description
Merrimack Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Merrimack Pharmaceuticals Inc – Strengths
Merrimack Pharmaceuticals Inc – Weaknesses
Merrimack Pharmaceuticals Inc – Opportunities
Merrimack Pharmaceuticals Inc – Threats
Merrimack Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Merrimack Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 05, 2020: Merrimack reports third quarter 2020 financial results
Aug 07, 2020: Merrimack reports second quarter 2020 financial results
May 07, 2020: Merrimack reports first quarter 2020 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Merrimack Pharmaceuticals Inc, Key Facts
Merrimack Pharmaceuticals Inc, Key Employees
Merrimack Pharmaceuticals Inc, Key Employee Biographies
Merrimack Pharmaceuticals Inc, Major Products and Services
Merrimack Pharmaceuticals Inc, History
Merrimack Pharmaceuticals Inc, Subsidiaries
Merrimack Pharmaceuticals Inc, Key Competitors
Merrimack Pharmaceuticals Inc, Ratios based on current share price
Merrimack Pharmaceuticals Inc, Annual Ratios
Merrimack Pharmaceuticals Inc, Annual Ratios (Cont...1)
Merrimack Pharmaceuticals Inc, Interim Ratios
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Merrimack Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Merrimack Pharmaceuticals Inc (MACK):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Approach Resources Inc. (AREX)-石油・ガス分野:企業M&A・提携分析
    Summary Approach Resources Inc. (Approach Resources) is an independent upstream oil and gas company. The company acquires oil and natural gas properties; and explores, develops and produces oil, natural gas and natural gas liquids (NGLs). It focuses on oil and gas reserves in oil shale and tight gas …
  • Magnus Life Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Magnus Life Ltd (Magnus) is a biomedical organization that funds, builds and manages companies to translate science into therapeutics and devices. The organization in involved in developing therapies for the treatment for obstetric conditions and pathologies of pregnancy including placental …
  • Mitsui E&S Holdings Co., Ltd. (7003):企業の財務・戦略的SWOT分析
    Mitsui E&S Holdings Co., Ltd. (7003) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Bank of America Corp:企業の戦略・SWOT・財務分析
    Bank of America Corp - Strategy, SWOT and Corporate Finance Report Summary Bank of America Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Knights of Columbus:企業の戦略的SWOT分析
    Knights of Columbus - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Proterra Inc:電力:M&Aディール及び事業提携情報
    Summary Proterra Inc.(Proterra), is engaged in designing and manufactureing of zero-emission electric buses. Its product portfolio includes a 35 foot and 40-foot transit vehicles. The company offers various services packages such as electric bill optimization, battery OH testing, onsite field servic …
  • Minoryx Therapeutics sl:製薬・医療:M&Aディール及び事業提携情報
    Summary Minoryx Therapeutics sl (Minoryx) is a clinical stage biotechnology company that develops treatments for life threatening rare diseases. The company offers discovery, preclinical research, development and clinical trial programs. It develops ALD-MIN, morquio B and PCT drugs used for lysosoma …
  • Alexander & Baldwin Inc (ALEX):企業の財務・戦略的SWOT分析
    Alexander & Baldwin Inc (ALEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Otsuka Pharmaceutical Co., Ltd.:企業のM&A・事業提携・投資動向
    Otsuka Pharmaceutical Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Otsuka Pharmaceutical Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Ceska rafinerska, a.s.-石油・ガス分野:企業M&A・提携分析
    Summary Ceska rafinerska, a.s. (Ceska rafinerska) is a crude oil refining company. It carries out the refining of crude oil, and production of petroleum based products. The company’s product portfolio includes automobile gasoline, diesel oil, aviation fuel, fuel oils, liquefied petroleum gas, heatin …
  • Energias de Portugal SA:企業の発電所・SWOT分析2018
    Energias de Portugal SA - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emplo …
  • Penske Automotive Group, Inc.:企業の戦略・SWOT・財務情報
    Penske Automotive Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Penske Automotive Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Banque Nationale Agricole SA:企業の戦略・SWOT・財務分析
    Banque Nationale Agricole SA - Strategy, SWOT and Corporate Finance Report Summary Banque Nationale Agricole SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • InfuSystem Holdings Inc (INFU):企業の財務・戦略的SWOT分析
    Summary InfuSystem Holdings Inc (InfuSystem) is a provider of infusion pumps and related services. The company provides ambulatory infusion pumps and associated clinical services. Its patient services comprise infucare help hotline, infuease, education, and pain management. InfuSystem offers pumps a …
  • Eskom Holdings SOC Ltd:電力:M&Aディール及び事業提携情報
    Summary Eskom Holdings SOC Ltd (Eskom) is a state-owned power utility that generates, transmits and distributes electricity. It generates electricity from coal-fired, gas-fired, hydro and pumped storage power plants, and nuclear power plants, among others. The company supplies electricity to industr …
  • Bombril SA (BOBR4):企業の財務・戦略的SWOT分析
    Bombril SA (BOBR4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Shanghai Electric Group Co Ltd:企業のM&A・事業提携・投資動向
    Shanghai Electric Group Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Shanghai Electric Group Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Samart Corporation Public Co Ltd (SAMART):企業の財務・戦略的SWOT分析
    Samart Corporation Public Co Ltd (SAMART) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • vTv Therapeutics Inc (VTVT)-製薬・医療分野:企業M&A・提携分析
    Summary vTv Therapeutics Inc (vTv), formerly TransTech Inc is a clinical stage pharmaceutical company that discovers, develops and commercializes small molecule drug candidates. The company’s pipeline products include azeliragon, TTP399, TTP273, HPP593, HPP737, HPP971 and hexokinase II inhibitors. I …
  • MeVis Medical Solutions AG (M3V)-医療機器分野:企業M&A・提携分析
    Summary MeVis Medical Solutions AG (MMS AG) is a medical technology company. It develops and offers medical imaging solutions for digital computer-aided medical imaging. The software solutions are used in screening, diagnostics, therapy and intervention planning for breast, lung, colon, and prostate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆